Back
#1
31.0%
#1
15.8%
Top 1%
9.8%
Top 72%
6.4%
Top 53%
5.4%
Top 1%
4.2%
Top 7%
3.3%
Top 0.4%
2.1%
Top 11%
1.7%
Top 53%
1.7%
Top 48%
1.3%
Top 3%
1.3%
Top 7%
1.0%
Top 4%
1.0%
Top 7%
1.0%
Top 8%
0.8%
Top 12%
0.8%
Sitagliptin decreases visceral fat and blood glucose in women with polycystic ovarian syndrome
2019-07-13
endocrinology
Title + abstract only
View on medRxiv
Show abstract
ContextWomen with polycystic ovarian syndrome (PCOS) have decreased growth hormone (GH), which can increase visceral adiposity (VAT) and impair vascular function. GH releasing hormone, a dipeptidyl peptidase-4 (DPP4) substrate, stimulates GH secretion. ObjectiveWe tested the hypothesis that DPP4 inhibition increases GH and improves glucose levels and vascular function in women with PCOS. MethodsEighteen women with PCOS participated in a double-blinded, cross-over study. They received sitaglipt...
Predicted journal destinations
1
The Journal of Clinical Endocrinology & Metabolism
26 training papers
2
Frontiers in Endocrinology
20 training papers
3
eLife
262 training papers
4
PLOS ONE
1737 training papers
5
Scientific Reports
701 training papers
6
Diabetologia
23 training papers
7
BMC Medicine
155 training papers
8
International Journal of Obesity
17 training papers
9
Journal of Clinical Medicine
77 training papers
10
BMJ Open
553 training papers
11
Nature Communications
483 training papers
12
Nutrients
43 training papers
13
Journal of Affective Disorders
72 training papers
14
Communications Medicine
63 training papers
15
PLOS Genetics
39 training papers
16
JCI Insight
63 training papers
17
Heliyon
57 training papers